Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818369) titled 'Synbiotic LA-5 and Agave Inulin for Mild Cognitive Impairment' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Anahuac University
Condition:
Cognitive Impairment
Intervention:
Dietary Supplement: Synbiotic (Lactobacillus acidophilus LA-5 and Agave Inulin) Intervention Type:
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: December 31, 2026
Target Sample Size: 20
Countries of Recruitment:
Mexico
To know more, visit http...